If youre bullish on oil, then Continental Resources (CLR) is the stock for you. I believe the company will likely significantly grow its earnings in 2018 due to higher realized prices and around 20% production growth. Meanwhile the company, which burned cash flows in 2017, will likely report str
Oil prices are coming back to life. Global demand is soaring on the back of booming global GDP growth and oil inventories are plummeting even during winter which is a historically slow period for demand. As oil prices and the cash flow of oil companies rise, oil producers will inevitably return
On Friday, our Elite Opportunity Pronewsletter suggestedhad this to say about gold and leveraged gold ETFs:
It’s our thinking gold is likely to reverse its recent bullish trend one more time before we’ll know if it wants to finally bottom for a good while. It’s important to remember hindsight is always brilliant, and it can make a fool out of anyone. However, we’re....More>>>
April 7, 2017: Markets opened nearly flat Friday and did not gather any positive strength until mid-day. Telecom and consumer staples were the top performing sectors while the utilities and energy sectors lagged. WTI crude oil for May delivery settled at $52.24 a barrel, up 1% on the day and at its highest level since March 7. June gold added 0.3% on the day to settle at $1,257.30. Equities were....More>>>
Big banks have gotten a boost today from JPMorgan Chase’s (JPM) dividend increase, and the hawkish Fed minutes, because higher rates are still expected to help banks out despite what happened last time. In a note previewing Wells Fargo’s (WFC) investor day on May 24, Jefferies analyst Ken Usdin and team write that “higher rates help, but other items weigh on longer-term net-interest-margin....More>>>
After five weeks of consecutive gains, the major U.S. stock indices closed in the red last week. They were led lower by the Russell 2000, which declined 2%.
In the March 14 Market Outlook, I said that a chart pattern in the Russell 2000 targeted an eventual 19% decline to 880 as long as the 1,096 area loosely held as overhead resistance. The small-cap index traded as high as 1,104 on March....More>>>
Perhaps you received a modest tax refund or an unexpected gift. Or maybe you just happened to be walking down the street and saw a $100 bill flapping against the pavement, waiting to be claimed. (Hey, stranger things have happened.) Your first inclination might be to spend your newfound mini-fortune, rather than doing something responsible with that money — especially since $100 is hardly....More>>>
Thanks to everyone who joined us for our special event earlier this week… It was among the most valuable we've held to date, and the early feedback from attendees has been incredibly positive. If you missed it, Porter and Stansberry Research senior analyst Bryan Beach walked attendees through their "10x Project" research… and officially unveiled our....More>>>
Barclays analyst Jason Goldberg and team have “long been attracted to” shares of JPMorgan Chase (JPM), even before news that CEO Jamie Dimon spent $26 million dollars to buy shares in the mega-bank. With JPMorgan’s investor day coming up on Feb. 23, they explain why:
Photo: Michael Nagle/Bloomberg
We have long been attracted to the shares of JPMorgan, given....More>>>
Under Armour INC (NYSE:UA) released a new line called Under Armour Sportswear in New York Fashion Week on 15th September. This line includes different collection of clothes like $200 woolen pants and $1,500 trench coats. It does not have athleisure component to them and the designers have targeted this new line at “ambitious millennials” who are looking at something different than the....More>>>
Merrimack Pharmaceuticals Inc., (NASDAQ:MACK) is a biopharmaceutical company engaged in building one of the most robust oncology pipeline of cures in the industry. Merrimack’s first commercial product Onivyde (Irinotecan liposome injection) for treatment of pancreatic cancer was approved by the US FDA in October 2015. In July 2016, the company announced that Onivyde had obtained a positive....More>>>
Money Morning Director of Technology & Venture Capital Research Michael Robinson is still a big fan of Bitcoin and many of the other cryptocurrencies out there. But he acknowledges that they are not for everyone.
Shares of Kura Oncology (KURA) have risen by more than 90% since I presented the idea to readers in September of last year. The stock has climbed 38% since my update piece published in late November in which I stated my expectations of continued upside due to multiple clinical catalysts in 2018
Yet another profit upgrade sent Fever-Tree Drinks Plc shares soaring in early London trading, propping up an already giddy valuation for the U.K. maker of premium tonic water and lemonade. Shore Capital analysts say that while they can see the growth opportunity, a price-to-earnings ratio o
Singapore's largest property developer, CapitaLand (OTCPK:CLLDY) (CATL.SI) had a pretty good 2017. Helped by improving conditions in Singapore and China, not to mention significant project openings, CapitaLand's local shares climbed 20% and the ADRs did even better.